Type here...

Home
About
Editor’s Corner
Contribute
Contact Us

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner

Instagram

Twitter

Sunday, July 26, 2026

28.3 C

Bengaluru

Home
About
Editor’s Corner
Contribute
Contact Us

My account

Get into your account.

type here...

Facebook

Twitter

Youtube

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

“Sales at Any Cost” is Not Sustainable in the Long Run

For commercial organisations, profits are important. But it cannot be 'at any cost' and certainly not at the cost of human life. As healthcare providers helping to mitigate the pain and misery of millions of human beings, we need to remember that charity begins at home.

Time for Pharma to Re-think its Way of Working

https://www.youtube.com/watch?v=BOO_CNxEzwQ Too many Medical Reps are chasing too few doctors,...

Navigating India’s Diverging Health Landscape and Field Force Optimisation

India’s health map is splitting into two distinct opportunity...

National Seminar on UCPMP

The seminar will help companies especially Product Management Teams and Sales Teams to understand their changing roles due to UCPMP. It will also bring clarity on strategies and promotional inputs including CME's, sampling, gifts etc.

Healthcare’s New Anti‑Fraud Playbook Will Reshape Hospitals, Pharma, Devices and Diagnostics

India’s AI‑enabled, anti‑FWA, interoperable roadmap is not a “payer‑only”...

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Marketing

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Policies/Sales

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Strategy

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

Eli Lilly’s $6.5 Billion Houston Bet: A Strategic Play in U.S. Manufacturing, Policy, and the Next Wave of Obesity Treatment

When Eli Lilly announced plans to build a $6.5...

DigiStorm 2018: Intent, Content, Strategy and Skills

The pharma industry in India is entering a very interesting variant of the post-digital marketing era. The term “post-digital marketing” is used to depict a state where the lines between physical and digital blur considerably for a customer. However, in the context of pharma, this means a state where the industry has stopped questioning the need for digital and has begun to implement very interesting digital marketing initiatives.

DiME (Digi MarketEr):-TiME to SHiNE

The new sparkling DIME (Digi MarketEr) are the ones who embrace digital transformation with open arms and voraciously feed on data analytics to satisfy their performance outcomes with an informed business decision. The benefit of being DIME is that it propels data management out of the hands of individual stakeholders, and puts data sets with insights on to center glass table (Transparent workplace) for informed decision making.